---
title: "HPGC: Norfloxacin capsules (0.1g) passed the consistency evaluation of quality and efficacy for generic drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245039948.md"
description: "HPGC announced that its norfloxacin capsules (0.1g) have passed the consistency evaluation of quality and efficacy for generic drugs by the National Medical Products Administration. This approval will provide greater support for the drug in areas such as medical insurance reimbursement and procurement by medical institutions, helping to expand market share and enhance competitiveness, while also accumulating experience for the company's future generic drug products"
datetime: "2025-06-18T08:02:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245039948.md)
  - [en](https://longbridge.com/en/news/245039948.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245039948.md)
---

# HPGC: Norfloxacin capsules (0.1g) passed the consistency evaluation of quality and efficacy for generic drugs

According to the news from Zhitong Finance APP, HPGC (600664.SH) announced that recently, its affiliated enterprise, Harbin Pharmaceutical Group Pharmaceutical General Factory (hereinafter referred to as "Harbin Pharmaceutical General Factory"), received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration regarding Norfloxacin Capsules. This product has passed the consistency evaluation of quality and efficacy for generic drugs.

According to relevant national policies, drug varieties that pass the consistency evaluation of quality and efficacy for generic drugs will receive greater support in areas such as medical insurance payments and procurement by medical institutions. The Norfloxacin Capsules (0.1g) from Harbin Pharmaceutical General Factory passing the consistency evaluation of quality and efficacy for generic drugs is beneficial for expanding the market share of this drug, enhancing market competitiveness, and at the same time, it has accumulated valuable experience for the company in carrying out the consistency evaluation of quality and efficacy for subsequent products

### Related Stocks

- [600664.CN](https://longbridge.com/en/quote/600664.CN.md)

## Related News & Research

- [Daly: Seeing surcharges, which can be reversed, rather than price increases](https://longbridge.com/en/news/282341847.md)
- [UKRAINE'S ZELENSKIY: NO CONFIRMATION ON TIMING OF WITKOFF & KUSHNER VISIT TO UKRAINE](https://longbridge.com/en/news/282742900.md)
- [Nevada Organic Phosphate Announces Compensation Share Issuance | NOPFF Stock News](https://longbridge.com/en/news/282742374.md)
- [SEM Holdings Controlling Shareholder Sells 9% Stake in Business](https://longbridge.com/en/news/282482959.md)
- [Private jets are flocking to a small regional airport for The Masters, the billionaires' favorite golf tournament](https://longbridge.com/en/news/282380257.md)